Upaget
Generic Name
Upadacitinib
Packs Price
Company
Getz
Therapeutic Group
Immunomodulators
Indication Dosage
Indication:
Upadacitinib is a Janus kinase (JAK) inhibitor used for:
Rheumatoid Arthritis (RA) – Joint pain and swelling.Psoriatic Arthritis (PsA) – Joint pain with skin issues.Ankylosing Spondylitis (AS) – Back and spine pain.Non-Radiographic Axial Spondyloarthritis (nr-axSpA) – Spine pain with inflammation.Atopic Dermatitis (Eczema) – Severe skin itching and rashes.Ulcerative Colitis (UC) & Crohn’s Disease (CD) – Inflammatory bowel diseases.Dosage:
For Arthritis (RA, PsA, AS, nr-axSpA): 15 mg once daily.
For Severe Eczema (Atopic Dermatitis):
Adults: 15 mg or 30 mg once daily. Children (≥12 years): 15 mg if weight is 40-60 kg, 30 mg if above 60 kg. For Ulcerative Colitis & Crohn’s Disease:
Starting dose: 45 mg once daily for 8 weeks. After 8 weeks: 15 mg or 30 mg once daily.
Content
Tab 15mg, 30mg, 45mg: Upadacitinib 15mg, 30mg, 45mg
Pregnancy
Not Recommended
Stability
Janus Kinase (JAK) Inhibitor
Contra Indications
Upadacitinib is contraindicated in severe infections (TB, sepsis), liver disease, history of blood clots, severe heart conditions, pregnancy, breastfeeding, and live vaccine use.
Precautions
Upadacitinib is contraindicated in severe infections (TB, sepsis), liver disease, history of blood clots, severe heart conditions, pregnancy, breastfeeding, and live vaccine use.
Lactation
Side Effects
Infections (TB, herpes, pneumonia)
Headache
Nausea
Fatigue
Acne
Increased Liver Enzymes
High Blood Pressure
Cough